13
H index
17
i10 index
614
Citations
University of Melbourne (47% share) | 13 H index 17 i10 index 614 Citations RESEARCH PRODUCTION: 56 Articles 51 Papers 4 Books RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Nancy Devlin. | Is cited by: | Cites to: |
Journals with more than one article published | # docs |
---|---|
Health Economics | 15 |
The European Journal of Health Economics | 11 |
PharmacoEconomics | 10 |
Health Policy | 6 |
Social Science & Medicine | 4 |
Applied Health Economics and Health Policy | 2 |
PharmacoEconomics - Open | 2 |
Working Papers Series with more than one paper published | # docs |
---|---|
Research Papers / Office of Health Economics | 26 |
Working Papers / Department of Economics, City University London | 11 |
Consulting Reports / Office of Health Economics | 6 |
Working Papers / Centre for Health Economics, University of York | 5 |
Year | Title of citing document | |
---|---|---|
2020 | A systematic review of child-focused outcomes and assessments of arts therapies delivered in primary mainstream schools. (2020). Powell, Joanne ; Karkou, Vicky ; Aithal, Supritha ; Moula, Zoe. In: Children and Youth Services Review. RePEc:eee:cysrev:v:112:y:2020:i:c:s0190740919313040. Full description at Econpapers || Download paper | |
2020 | Living up to expectations: Experimental tests of subjective life expectancy as reference point in time trade-off and standard gamble. (2020). Brouwer, Werner ; Attema, Arthur ; Lipman, Stefan A. In: Journal of Health Economics. RePEc:eee:jhecon:v:71:y:2020:i:c:s0167629619302279. Full description at Econpapers || Download paper | |
2020 | Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework. (2020). Molina-Lopez, T ; Montibeller, G ; Linch, M ; Angelis, A ; Kanavos, P ; Espin, J ; Arickx, F ; Orzel, K ; Zawada, A. In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953619305908. Full description at Econpapers || Download paper | |
2020 | Can healthcare choice be predicted using stated preference data?. (2020). Swait, Joffre ; Donkers, Bas ; Bliemer, Michiel ; de Bekker-Grob, E W ; Veldwijk, J ; Bliemer, M. C. J., . In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953619307312. Full description at Econpapers || Download paper | |
2020 | Examining the transnational health preferences of a group of Eastern European migrants relative to a European host population using the EQ-5D-5L. (2020). O'Neill, Stephen ; Hobbins, Anna ; Barry, Luke ; Kelleher, Dan ; Doherty, Edel. In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953620300204. Full description at Econpapers || Download paper | |
2020 | Health and wellbeing in Norway: Population norms and the social gradient. (2020). Lamu, Admassu Nadew ; Lindberg, Marie Hella ; Olsen, Jan Abel. In: Social Science & Medicine. RePEc:eee:socmed:v:259:y:2020:i:c:s0277953620303749. Full description at Econpapers || Download paper | |
2020 | Understanding the composite dimensions of the EQ-5D: An experimental approach. (2020). Tsuchiya, Aki ; Mullett, Timothy L ; McDonald, Rebecca. In: Social Science & Medicine. RePEc:eee:socmed:v:265:y:2020:i:c:s0277953620305426. Full description at Econpapers || Download paper | |
2020 | Complexity Stage Model of the Medical Device Development Based on Economic Evaluation—MedDee. (2020). Peter, Luka ; Mareova, Petra ; Kua, Kamil ; Klimova, Blanka ; Mohelska, Hana ; Augustnek, Martin ; Penhaker, Marek ; Ren, Luka ; Honegr, Jan. In: Sustainability. RePEc:gam:jsusta:v:12:y:2020:i:5:p:1755-:d:325509. Full description at Econpapers || Download paper | |
2020 | Mass media coverage and vaccination uptake: evidence from the demand for meningococcal vaccinations in Hungary. (2020). Szabo-Morvai, Agnes ; Biro, Aniko. In: IEHAS Discussion Papers. RePEc:has:discpr:2018. Full description at Econpapers || Download paper | |
2020 | Performance Management Strategy: Waiting Time in the English National Health Services. (2020). Cookson, Graham ; Elkomy, Shimaa. In: Public Organization Review. RePEc:kap:porgrv:v:20:y:2020:i:1:d:10.1007_s11115-018-0425-7. Full description at Econpapers || Download paper | |
2020 | Elicitation and modelling of imprecise utility of health states. (2020). Golicki, Dominik ; Jakubczyk, Micha. In: Theory and Decision. RePEc:kap:theord:v:88:y:2020:i:1:d:10.1007_s11238-019-09707-6. Full description at Econpapers || Download paper | |
2020 | Health-related quality of life among patients with type 2 diabetes mellitus in Eastern Province, Saudi Arabia: A cross-sectional study. (2020). Joseph, Royes ; Alshayban, Dhfer. In: PLOS ONE. RePEc:plo:pone00:0227573. Full description at Econpapers || Download paper | |
2020 | A two-step procedure to generate utilities for the Infant health-related Quality of life Instrument (IQI). (2020). , Paul ; Vermeulen, Karin M ; Dainelli, Livia ; Detzel, Patrick ; Jabrayilov, Ruslan. In: PLOS ONE. RePEc:plo:pone00:0230852. Full description at Econpapers || Download paper | |
2020 | Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review. (2020). Ridyard, Colin H ; Okeah, Bernard O. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:5:d:10.1007_s40258-020-00576-7. Full description at Econpapers || Download paper | |
2020 | A Systematic Review of the Association Between Hospital Cost/price and the Quality of Care. (2020). Schreyogg, Jonas ; Winter, Vera ; Jamalabadi, Sara. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:5:d:10.1007_s40258-020-00577-6. Full description at Econpapers || Download paper | |
2020 | Economic evaluation of meningococcal vaccines: considerations for the future. (2020). Shah, Koonal ; Lorgelly, Paula ; York, Laura ; Landa, Paolo ; Wright, Claire ; Bloom, David E ; Glennie, Linda ; Postma, Maarten J ; Smith, Vinny ; Levy, Pierre ; HERNaNDEZ-VILLAFUERTE, KARLA ; Al-Janabi, Hareth ; Christensen, Hannah ; Towse, Adrian K ; Diez-Domingo, Javier ; Salisbury, David M ; Farkouh, Raymond ; Damm, Oliver . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:2:d:10.1007_s10198-019-01129-z. Full description at Econpapers || Download 2020 | Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy. (2020). Rodriguez-Sanchez, B ; Sinclair, A J ; Pea-Longobardo, L M. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:3:d:10.1007_s10198-019-01134-2. Full description at Econpapers || Download paper |
2020 | A vision ‘bolt-on’ increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery. (2020). Gandhi, Mihir ; Luo, Nan ; Janssen, Mathieu F ; Tan, Rachel Lee-Yin ; Wei, Yvonne Chung-Hsi ; Wong, Chee Wai ; Teo, Kelvin ; Ang, Marcus. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:4:d:10.1007_s10198-019-01156-w. Full description at Econpapers || Download paper | |
2020 | Transforming discrete choice experiment latent scale values for EQ-5D-3L using the visual analogue scale. (2020). Wright, Penny ; Kind, Paul ; Meads, David ; Odwyer, John. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:5:d:10.1007_s10198-020-01173-0. Full description at Econpapers || Download paper | |
2020 | Does linear equating improve prediction in mapping? Crosswalking MacNew onto EQ-5D-5L value sets. (2020). Lamu, Admassu N. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:6:d:10.1007_s10198-020-01183-y. Full description at Econpapers || Download paper | |
2020 | Discrete choice experiments to generate utility values for multi-attribute utility instruments: a systematic review of methods. (2020). Bahrampour, Mina ; Downes, Martin ; Scuffham, Paul A ; Norman, Richard ; Byrnes, Joshua. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:7:d:10.1007_s10198-020-01189-6. Full description at Econpapers || Download paper | |
2020 | Measuring intangible cost-of-morbidity due to substance dependence: implications of using alternative preference-based instruments. (2020). Casal, Bruno ; Rivera, Berta ; Rodriguez-Miguez, Eva . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:7:d:10.1007_s10198-020-01196-7. Full description at Econpapers || Download paper | |
2020 | Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. (2020). Reenen, Mandy ; Herdman, Michael ; Slaap, Bernhard ; Kennedy-Martin, Matthew ; Boye, Kristina S ; Busschbach, Jan ; Greiner, Wolfgang. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:8:d:10.1007_s10198-020-01195-8. Full description at Econpapers || Download paper | |
2020 | EQ-5D-5L Bulgarian population norms. (2020). Golicki, Dominik ; Vekov, Toni ; Djambazov, Slaveyko ; Encheva, Marta. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:8:d:10.1007_s10198-020-01225-5. Full description at Econpapers || Download paper | |
2020 | HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies. (2020). Shah, Koonal ; Graf von der Schulenburg, Johann ; Shen, Jie ; Durand-Zaleski, Isabelle ; Ratcliffe, Mark ; Coyle, Doug ; Pemberton-Whiteley, Zack ; Palmer, Stephen ; Moutie, Anne-Sophie ; Meunier, Aurelie ; Longworth, Louise ; Greiner, Wolfgang ; Zhao, Kun ; Garrison, Louis ; Sproule, Doug ; Farrington, Jasmine. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:9:d:10.1007_s10198-020-01212-w. Full description at Econpapers || Download 2020 | Multiplicative modelling of EQ-5D-3L TTO and VAS values. (2020). Thakumar, Annushiah Vasan ; Shafie, Asrul Akmal. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:9:d:10.1007_s10198-020-01233-5. Full description at Econpapers || Download paper |
2021 | Increasing respondent engagement in composite time trade-off tasks by imposing three minimum trade-offs to improve data quality. (2021). Kohlmann, Thomas ; Jiang, Ruixuan ; Pickard, Simon A ; Walton, Surrey ; shaw, james ; Muhlbacher, Axel ; Lee, Todd A. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:1:d:10.1007_s10198-020-01224-6. Full description at Econpapers || Download paper | |
2020 | The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment. (2020). Boes, Stefan ; Wettstein, Dominik J. In: Health Economics Review. RePEc:spr:hecrev:v:10:y:2020:i:1:d:10.1186_s13561-020-00267-y. Full description at Econpapers || Download paper | |
2020 | A Picture is Worth a Thousand Words: The Role of Survey Training Materials in Stated-Preference Studies. (2020). Vass, Caroline M ; Payne, Katherine ; Stichele, Geert ; Davison, Niall J. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:13:y:2020:i:2:d:10.1007_s40271-019-00391-w. Full description at Econpapers || Download paper | |
2021 | Giving a Voice to Marginalised Groups for Health Care Decision Making. (2021). Watson, JO ; Ratcliffe, Julie ; Ong, Jason J ; Howard, Kirsten ; Devlin, Nancy ; de Abreu, Richard ; Huynh, Elisabeth ; Willing, Esther. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:14:y:2021:i:1:d:10.1007_s40271-020-00456-1. Full description at Econpapers || Download paper | |
2020 | Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach. (2020). Lomas, James ; Gu, Yuanyuan ; Wang, Haiyin ; Ochalek, Jessica ; Jin, Chunlin ; Cutler, Henry. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:12:d:10.1007_s40273-020-00954-y. Full description at Econpapers || Download paper | |
2020 | After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?. (2020). Palmer, Stephen ; Sculpher, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:3:d:10.1007_s40273-019-00882-6. Full description at Econpapers || Download paper | |
2020 | A French Value Set for the EQ-5D-5L. (2020). Andrade, Luiz Flavio ; Pouvourville, Gerard ; Oppe, Mark ; Ramos, Juan Manuel ; Ludwig, Kristina. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:4:d:10.1007_s40273-019-00876-4. Full description at Econpapers || Download paper | |
2020 | Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best–Worst Scaling. (2020). Dalziel, Kim ; Rivero-Arias, Oliver ; Norman, Richard ; Gorostiza, Inigo ; Garcia-Lorenzo, Borja ; Catchpool, Max. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:5:d:10.1007_s40273-020-00884-9. Full description at Econpapers || Download paper | |
2020 | Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States. (2020). Gerdtham, Ulf-G. ; Leidl, Reiner ; Ulf-G. Gerdtham, ; Ulf- G. Gerdtham, ; Teni, Fitsum Sebsibe ; Burstrom, Kristina ; Henriksson, Martin ; Rolfson, Ola ; Helgesson, Gert. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00905-7. Full description at Econpapers || Download paper | |
2021 | Modifying NICE’s Approach to Equity Weighting. (2021). McCabe, Christopher ; Paulden, Mike. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00988-2. Full description at Econpapers || Download paper | |
2021 | NICE’s Discounting Review: Clear Thinking on Rational Revision Meets Obstacle of Industrial Interests. (2021). Paulden, Mike ; Omahony, James F ; McCabe, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00990-8. Full description at Econpapers || Download paper | |
2020 | Is Protocolised Weaning that Includes Early Extubation Onto Non-Invasive Ventilation More Cost Effective Than Protocolised Weaning Without Non-Invasive Ventilation? Findings from the Breathe Study. (2020). Maredza, Mandy ; Khan, Iftekhar ; Petrou, Stavros ; Perkins, Gavin D ; Gates, Simon ; Couper, Keith ; Lamb, Sarah E ; Lall, Ranjit ; Mistry, Dipesh ; Dritsaki, Melina. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00210-1. Full description at Econpapers || Download 2020 | The efficiency of hospitals: platform for sustainable health care system. (2020). Kocisova, Kristina ; Gavurova, Beata. In: Entrepreneurship and Sustainability Issues. RePEc:ssi:jouesi:v:8:y:2020:i:2:p:133-146. Full description at Econpapers || Download paper |
2020 | Tolerance intervals for autoregressive models, with an application to hospital waiting lists. (2020). Cheng, Kedai ; Young, Derek S. In: Applied Stochastic Models in Business and Industry. RePEc:wly:apsmbi:v:36:y:2020:i:2:p:268-282. Full description at Econpapers || Download paper | |
2020 | What is it going to be, TTO or SG? A direct test of the validity of health state valuation. (2020). Attema, Arthur ; Lipman, Stefan A. In: Health Economics. RePEc:wly:hlthec:v:29:y:2020:i:11:p:1475-1481. Full description at Econpapers || Download paper | |
2021 | Social tariffs and democratic choice—Do population?based health state values reflect the will of the people?. (2021). Schneider, Paul Peter. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:1:p:104-112. Full description at Econpapers || Download paper |
Year | Title | Type | Cited |
---|---|---|---|
1995 | Comment: Financing New Zealand’s Tertiary Education: How Much Subsidy? In: Agenda - A Journal of Policy Analysis and Reform. [Full Text][Citation analysis] | article | 0 |
1994 | The effects of denturism: New Zealand dentists response to competition In: American Journal of Public Health. [Citation analysis] | article | 0 |
2000 | The health state preferences and logistical inconsistencies of New Zealanders: a tale of two tariffs In: Working Papers. [Full Text][Citation analysis] | paper | 1 |
2011 | Truly inefficient or providing better quality of care? Analysing the relationship between riskadjusted hospital costs and patients’ health outcomes In: Working Papers. [Full Text][Citation analysis] | paper | 20 |
2013 | TRULY INEFFICIENT OR PROVIDING BETTER QUALITY OF CARE? ANALYSING THE RELATIONSHIP BETWEEN RISKâ€ADJUSTED HOSPITAL COSTS AND PATIENTS HEALTH OUTCOMES.(2013) In: Health Economics. [Full Text][Citation analysis] This paper has another version. Agregated cites: 20 | article | |
2012 | Analysing Hospital Variation in Health Outcome at the Level of EQ-5D Dimensions In: Working Papers. [Full Text][Citation analysis] | paper | 1 |
2013 | Methods for the estimation of the NICE cost effectiveness threshold In: Working Papers. [Full Text][Citation analysis] | paper | 42 |
2013 | The influence of cost-effectiveness and other factors on NICE decisions In: Working Papers. [Full Text][Citation analysis] | paper | 30 |
2013 | The Influence of Cost-effectiveness and Other Factors on NICE Decisions.(2013) In: Research Papers. [Full Text][Citation analysis] This paper has another version. Agregated cites: 30 | paper | |
2015 | The Influence of Costâ€Effectiveness and Other Factors on Nice Decisions.(2015) In: Health Economics. [Full Text][Citation analysis] This paper has another version. Agregated cites: 30 | article | |
2003 | Does NICE have a cost effectiveness threshold and what other factors influence its decisions? A discrete choice analysis In: Working Papers. [Full Text][Citation analysis] | paper | 3 |
2004 | Is there a case for using Visual Analogue Scale valuations in Cost-Utility Analysis? In: Working Papers. [Full Text][Citation analysis] | paper | 25 |
2006 | Is there a case for using visual analogue scale valuations in costâ€utility analysis?.(2006) In: Health Economics. [Full Text][Citation analysis] This paper has another version. Agregated cites: 25 | article | |
2004 | A theoretical framework for TTO valuations and a taxonomy of TTO approaches: results from a pilot study In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
2005 | Understanding individuals’ decisions about vaccination: a comparison between Expected Utility and Regret Theory models In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
2006 | The impact of government targets on waiting times for elective surgery: new insights from time-to-event analysis In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
2008 | A note on the nature of utility in time and health and implications for cost utility analysis In: Working Papers. [Full Text][Citation analysis] | paper | 3 |
2009 | A note on the nature of utility in time and health and implications for cost utility analysis.(2009) In: Social Science & Medicine. [Full Text][Citation analysis] This paper has another version. Agregated cites: 3 | article | |
2008 | Statistical analysis of EQ-5D profiles: does the use of value sets bias inference? In: Working Papers. [Full Text][Citation analysis] | paper | 3 |
2009 | Using the EQ-5D as a performance measurement tool in the NHS In: Working Papers. [Full Text][Citation analysis] | paper | 2 |
2009 | Does the value of quality of life depend on duration? In: Working Papers. [Full Text][Citation analysis] | paper | 2 |
2009 | A uniform Time Trade Off method for states better and worse than dead: feasibility study of the ‘lead time’ approach In: Working Papers. [Full Text][Citation analysis] | paper | 25 |
2011 | A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead time’ approach.(2011) In: Health Economics. [Full Text][Citation analysis] This paper has another version. Agregated cites: 25 | article | |
2013 | A Study of the Relationship Between Health and Subjective Well-being in Parkinson’s Disease Patients In: Working Papers. [Full Text][Citation analysis] | paper | 3 |
2013 | A Study of the Relationship Between Health and Subjective Well-being in Parkinsons Disease Patients.(2013) In: Research Papers. [Full Text][Citation analysis] This paper has another version. Agregated cites: 3 | paper | |
2015 | Local health care expenditure plans and their opportunity costs In: Health Policy. [Full Text][Citation analysis] | article | 3 |
2020 | Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in Ireland In: Health Policy. [Full Text][Citation analysis] | article | 0 |
2020 | The impact of price transparency on consumers and providers: A scoping review In: Health Policy. [Full Text][Citation analysis] | article | 0 |
1996 | The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand In: Health Policy. [Full Text][Citation analysis] | article | 6 |
2006 | Yes, No or Yes, but? Multinomial modelling of NICE decision-making In: Health Policy. [Full Text][Citation analysis] | article | 6 |
2009 | Searching for cost effectiveness thresholds in the NHS In: Health Policy. [Full Text][Citation analysis] | article | 18 |
2020 | A new tool for creating personal and social EQ-5D-5L value sets, including valuing ‘dead’ In: Social Science & Medicine. [Full Text][Citation analysis] | article | 0 |
1999 | The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule In: Social Science & Medicine. [Full Text][Citation analysis] | article | 2 |
2005 | Continuity through change: The rhetoric and reality of health reform in New Zealand In: Social Science & Medicine. [Full Text][Citation analysis] | article | 9 |
2009 | Identifying the impact of government targets on waiting times in the NHS In: Health Care Management Science. [Full Text][Citation analysis] | article | 33 |
2000 | Allocating Vote: Health — ‘Needs Assessment’ and an Economics-Based Approach In: Treasury Working Paper Series. [Full Text][Citation analysis] | paper | 0 |
2016 | New Age Decision Making in HTA: Is It Applicable in Asia? In: Briefings. [Full Text][Citation analysis] | paper | 0 |
2012 | Time Trends in NICE HTA Decisions In: Consulting Reports. [Full Text][Citation analysis] | paper | 0 |
2011 | The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response In: Consulting Reports. [Full Text][Citation analysis] | paper | 6 |
2015 | Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices? In: Consulting Reports. [Full Text][Citation analysis] | paper | 3 |
2016 | Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making In: Consulting Reports. [Full Text][Citation analysis] | paper | 2 |
2018 | Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology In: Consulting Reports. [Full Text][Citation analysis] | paper | 0 |
2019 | Public Preferences for Health Gains and Cures: A Discrete Choice Experiment In: Consulting Reports. [Full Text][Citation analysis] | paper | 1 |
2011 | Incorporating Multiple Criteria in HTA: Methods and Processes In: Monographs. [Full Text][Citation analysis] | book | 21 |
2010 | Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making In: Monographs. [Full Text][Citation analysis] | book | 7 |
2002 | Cost-Effectiveness Thresholds: Economic and ethical issues In: Monographs. [Full Text][Citation analysis] | book | 10 |
2004 | How Much Should We Spend on the NHS? In: Monographs. [Full Text][Citation analysis] | book | 1 |
2013 | Searching for Cost-effectiveness Thresholds in NHS Scotland In: Research Papers. [Full Text][Citation analysis] | paper | 0 |
2012 | Understanding Social Preferences Regarding the Prioritisation of Treatments Addressing Unmet Need and Severity In: Research Papers. [Full Text][Citation analysis] | paper | 4 |
2012 | Assessing the Performance of the EQ-VAS in the NHS PROMs Programme In: Research Papers. [Full Text][Citation analysis] | paper | 2 |
2011 | Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches In: Research Papers. [Full Text][Citation analysis] | paper | 1 |
2011 | Is the Aim of the Health Care System to Maximise QALYs? An Investigation of In: Research Papers. [Full Text][Citation analysis] | paper | 0 |
2010 | A Comparison of Alternative Variants of the Lead and Lag Time TTO In: Research Papers. [Full Text][Citation analysis] | paper | 14 |
2013 | A COMPARISON OF ALTERNATIVE VARIANTS OF THE LEAD AND LAG TIME TTO.(2013) In: Health Economics. [Full Text][Citation analysis] This paper has another version. Agregated cites: 14 | article | |
2014 | Opportunity Costs of Implementing NICE Decisions in NHS Wales In: Research Papers. [Full Text][Citation analysis] | paper | 1 |
2014 | What Determines the Shape of an EQ-5D Index Distribution? In: Research Papers. [Full Text][Citation analysis] | paper | 3 |
2015 | An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate EQ-5D-5L Values in the United Arab Emirates In: Research Papers. [Full Text][Citation analysis] | paper | 0 |
2016 | Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England In: Research Papers. [Full Text][Citation analysis] | paper | 51 |
2018 | Valuing healthâ€related quality of life: An EQâ€5Dâ€5L value set for England.(2018) In: Health Economics. [Full Text][Citation analysis] This paper has another version. Agregated cites: 51 | article | |
2016 | New Methods for Modelling EQ-5D-5L Value Sets: An Application to English Data In: Research Papers. [Full Text][Citation analysis] | paper | 15 |
2018 | New methods for modelling EQâ€5Dâ€5L value sets: An application to English data.(2018) In: Health Economics. [Full Text][Citation analysis] This paper has another version. Agregated cites: 15 | article | |
2016 | A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications In: Research Papers. [Full Text][Citation analysis] | paper | 3 |
2016 | The Distribution of the EQ-5D-5L Index in Patient Populations In: Research Papers. [Full Text][Citation analysis] | paper | 0 |
2016 | Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL) In: Research Papers. [Full Text][Citation analysis] | paper | 0 |
2018 | Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL).(2018) In: PharmacoEconomics - Open. [Full Text][Citation analysis] This paper has another version. Agregated cites: 0 | article | |
2016 | An Analysis of NICE Technology Appraisal Decisions Recommended in Line with Clinical Practice In: Research Papers. [Full Text][Citation analysis] | paper | 0 |
2017 | What is the Normative Basis for Selecting the Measure of Average Preferences for Use in Social Choices? In: Research Papers. [Full Text][Citation analysis] | paper | 1 |
2017 | Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets In: Research Papers. [Full Text][Citation analysis] | paper | 5 |
2018 | Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets.(2018) In: PharmacoEconomics. [Full Text][Citation analysis] This paper has another version. Agregated cites: 5 | article | |
2017 | Age and Utilities: Issues for HTA In: Research Papers. [Full Text][Citation analysis] | paper | 0 |
2017 | A New Valuation Method: Directly Eliciting Personal Utility Functions In: Research Papers. [Full Text][Citation analysis] | paper | 1 |
2018 | New Methods for Analysing the Distribution of EQ-5D Observations In: Research Papers. [Full Text][Citation analysis] | paper | 0 |
2019 | Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA In: Research Papers. [Full Text][Citation analysis] | paper | 1 |
2019 | Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England In: Research Papers. [Full Text][Citation analysis] | paper | 0 |
2019 | Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ? In: Research Papers. [Full Text][Citation analysis] | paper | 0 |
2020 | Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead In: Research Papers. [Full Text][Citation analysis] | paper | 0 |
2013 | The Effect of Perceived Risks on the Demand for Vaccination: Results from a Discrete Choice Experiment In: PLOS ONE. [Full Text][Citation analysis] | article | 6 |
2012 | Time to tweak the TTO. But how? In: MPRA Paper. [Full Text][Citation analysis] | paper | 0 |
2017 | EQ-5D and the EuroQol Group: Past, Present and Future In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 11 |
2017 | A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact? In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 3 |
2013 | The development of new research methods for the valuation of EQ-5D-5L In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 8 |
2013 | The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
2013 | Lead versus lag-time trade-off variants: does it make any difference? In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
2013 | Time to tweak the TTO: results from a comparison of alternative specifications of the TTO In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
2013 | One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
2017 | Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
2018 | Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
2019 | Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
2019 | A new method for valuing health: directly eliciting personal utility functions In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 4 |
2020 | An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
2005 | A ‘new and improved’ EQ-5D valuation questionnaire? In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
2017 | Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial In: The Patient: Patient-Centered Outcomes Research. [Full Text][Citation analysis] | article | 0 |
2010 | An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions In: PharmacoEconomics. [Full Text][Citation analysis] | article | 2 |
2013 | Operationalizing Value-Based Pricing of Medicines In: PharmacoEconomics. [Full Text][Citation analysis] | article | 10 |
2015 | A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE) In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
2018 | Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
2018 | 3L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
2018 | Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
2018 | Correction to: 3L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
2020 | Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going? In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
2020 | International Valuation Protocol for the EQ-5D-Y-3L In: PharmacoEconomics. [Full Text][Citation analysis] | article | 0 |
2019 | All Male Panels and Other Diversity Considerations for ISPOR In: PharmacoEconomics - Open. [Full Text][Citation analysis] | article | 0 |
2001 | Health care spending and economic output: Granger causality In: Applied Economics Letters. [Full Text][Citation analysis] | article | 41 |
2002 | The Purchasing of Health Care by Primary Care Organisations. An evaluation and Guide to Future Policy, by N. Mays, S. Wyke, G. Malbon, N. Goodwin. Open University Press, Buckingham and Philadelphia, 2 In: Health Economics. [Full Text][Citation analysis] | article | 0 |
2003 | Logical inconsistencies in survey respondents health state valuations †a methodological challenge for estimating social tariffs In: Health Economics. [Full Text][Citation analysis] | article | 11 |
2004 | Does NICE have a costâ€effectiveness threshold and what other factors influence its decisions? A binary choice analysis In: Health Economics. [Full Text][Citation analysis] | article | 99 |
2004 | Getting Health Economics into Practice, Edited by David Kernick. Radcliffe Medical Press, Oxford, 2002. No. of pages: 358. ISBN 1â€85775â€575â€8 In: Health Economics. [Full Text][Citation analysis] | article | 0 |
2006 | A theoretical framework for TTO valuations of health In: Health Economics. [Full Text][Citation analysis] | article | 4 |
2007 | ‘Is there a case for using visual analogue scale valuations in CUA? Yes there is a case, but what does it add to ordinal data?’ a rejoinder In: Health Economics. [Full Text][Citation analysis] | article | 0 |
2010 | Patientâ€reported outcome measures in the NHS: new methods for analysing and reporting EQâ€5D data In: Health Economics. [Full Text][Citation analysis] | article | 8 |
2015 | INTERâ€PROVIDER COMPARISON OF PATIENTâ€REPORTED OUTCOMES: DEVELOPING AN ADJUSTMENT TO ACCOUNT FOR DIFFERENCES IN PATIENT CASE MIX In: Health Economics. [Full Text][Citation analysis] | article | 1 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated November, 2 2021. Contact: CitEc Team